Search Results - Pierfranco Conte

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review by Mara Mantiero, Giovanni Faggioni, Alice Menichetti, Matteo Fassan, Valentina Guarneri, Pierfranco Conte

    Published in Case Reports in Oncological Medicine (2018-01-01)
    Get full text
    Article


  2. 2

    Healthcare costs of cutaneous melanoma according to comorbidity patterns: a population-based study from the Regional Cancer Registry of the Veneto Region by Alessandra Buja, Fortunato Cassalia, Massimo Rugge, Chiara Trevisiol, Manuel Zorzi, Paolo Del Fiore, Ilaria Pantaleo, Carlo Riccardo Rossi, Pierfranco Conte, Pierfranco Conte, Anna Belloni Fortina, Simone Mocellin, Simone Mocellin

    Published in Frontiers in Public Health (2025-10-01)
    Get full text
    Article


  3. 3

    Risk factors for 30-day unplanned readmissions after surgical procedures in the elderly population by Gino Sartor, Marco Fusco, Marzio Milana, Leonardo Rigon, Giorgio Arcara, Pierfranco Conte, Alessandra Buja

    Published in Patient Safety in Surgery (2025-07-01)
    Get full text
    Article


  4. 4

    Examining technology-assisted rehabilitation for older adults’ functional mobility: a network meta-analysis on efficacy and acceptability by Błażej Cieślik, Justyna Mazurek, Adam Wrzeciono, Lorenza Maistrello, Joanna Szczepańska-Gieracha, Pierfranco Conte, Pawel Kiper

    Published in npj Digital Medicine (2023-08-01)
    Get full text
    Article


  5. 5

    Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER... by Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D’amico, Pierfranco Conte, Valentina Guarneri

    Published in npj Breast Cancer (2023-04-01)
    Get full text
    Article


  6. 6

    Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial by Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D’amico, Pierfranco Conte, Valentina Guarneri

    Published in npj Breast Cancer (2023-02-01)
    Get full text
    Article


  7. 7

    ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis by Loredana Urso, Grazia Vernaci, Grazia Vernaci, Jessica Carlet, Marcello Lo Mele, Matteo Fassan, Elisabetta Zulato, Giovanni Faggioni, Alice Menichetti, Elisabetta Di Liso, Gaia Griguolo, Gaia Griguolo, Cristina Falci, Pierfranco Conte, Pierfranco Conte, Stefano Indraccolo, Stefano Indraccolo, Valentina Guarneri, Valentina Guarneri, Maria Vittoria Dieci, Maria Vittoria Dieci

    Published in Frontiers in Oncology (2021-03-01)
    Get full text
    Article


  8. 8

    “Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper” by Pierfranco Conte, Eva Ciruelos, Giuseppe Curigliano, Michelino De Laurentiis, Lucia Del Mastro, Alessandra Gennari, Antonio Llombart, Miguel Martìn, Francesca Poggio, Aleix Prat, Fabio Puglisi, Cristina Saura

    Published in Breast (2024-08-01)
    Get full text
    Article


  9. 9

    Genome-wide biomarker analysis across the full spectrum of HER2-expressing breast cancers to reveal a clonal chromosome 17 imbalance defining unfavourable HER2-low disease by Sara Erika Bellomo, Enrico Berrino, Pamela Arcella, Anita Chesta, Caterina Parlato, Simonetta Guarrera, Laura Casorzo, Ivana Sarotto, Mara Panero, Andrea Botticelli, Riccardo Ponzone, Pierfranco Conte, Nicola Crosetto, Anna Sapino, Caterina Marchiò

    Published in Biomarker Research (2026-04-01)
    Get full text
    Article


  10. 10

    Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer by Gaia Griguolo, Maria Vittoria Dieci, Laia Paré, Federica Miglietta, Daniele Giulio Generali, Antonio Frassoldati, Luigi Cavanna, Giancarlo Bisagni, Federico Piacentini, Enrico Tagliafico, Katia Cagossi, Guido Ficarra, Aleix Prat, Pierfranco Conte, Valentina Guarneri

    Published in npj Breast Cancer (2021-02-01)
    Get full text
    Article


  11. 11

    Title not available by Silvia Adami, Alfredo Alberti, Margherita Andretta, Giuliano Buzzetti, Enzo Bonora, Nicola Braggio, Maurizio Cancian, Ercole Concia, Pierfranco Conte, Michele De Boni, Valeria Fadda, Annalisa Ferrarese, Bruno Giometto, Roberto Leone, Vittorio Pengo, Paolo Pertile, Leonardo Punzi, Mauro Saugo, Giovanna Scroccaro, Andrea Vianello

    Get full text
    Article


  12. 12

    Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy by Giovanna Garufi, Luisa Carbognin, Isabella Sperduti, Federica Miglietta, Maria Vittoria Dieci, Roberta Mazzeo, Armando Orlandi, Lorenzo Gerratana, Antonella Palazzo, Alessandra Fabi, Ida Paris, Antonio Franco, Gianluca Franceschini, Elena Fiorio, Sara Pilotto, Valentina Guarneri, Fabio Puglisi, Pierfranco Conte, Michele Milella, Giovanni Scambia, Giampaolo Tortora, Emilio Bria

    Published in Therapeutic Advances in Medical Oncology (2023-03-01)
    Get full text
    Article


  13. 13

    Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified accordin... by Luisa Carbognin, Michele Simbolo, Anna Caliò, Caterina Vicentini, Pietro Delfino, Isabella Sperduti, Matteo Fassan, Francesco Schettini, Maria Vittoria Dieci, Gaia Griguolo, Sara Pilotto, Elena Fiorio, Grazia Arpino, Valentina Guarneri, Sabino De Placido, Pierfranco Conte, Erminia Manfrin, Matteo Brunelli, Giovanni Scambia, Aldo Scarpa, Giampaolo Tortora, Emilio Bria

    Published in Breast (2020-04-01)
    Get full text
    Article


  14. 14

    Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer by Aleix Prat, Valentina Guarneri, Tomás Pascual, Fara Brasó-Maristany, Esther Sanfeliu, Laia Paré, Francesco Schettini, Débora Martínez, Pedro Jares, Gaia Griguolo, Maria Vittoria Dieci, Javier Cortés, Antonio Llombart-Cussac, Benedetta Conte, Mercedes Marín-Aguilera, Nuria Chic, Joan Anton Puig-Butillé, Antonio Martínez, Patricia Galván, Yi-Hsuan Tsai, Blanca González-Farré, Aurea Mira, Ana Vivancos, Patricia Villagrasa, Joel S. Parker, Pierfranco Conte, Charles M. Perou

    Published in EBioMedicine (2022-01-01)
    Get full text
    Article


Search Tools: